2020
24 June

COVID-19 risks turning back the clock on years of essential development work
20 May

Reflections on the World Health Assembly
5 March

Europe’s Beating Cancer Plan
2019
13 November

Statement from the ACCISS Study regarding the WHO announcement of the first-ever insulin prequalification programme
27 September

Biased cancer drug trials are only good for one group…and it’s not patients
26 June

In Memory of Royjan Taylor
2018
3 December

HAI and Snakebite Programme Partner, James Ashe Antivenom Trust, Applaud Government Action on Antivenom at Bio-Ken Snakebite Symposium
2015
12 November

HSA4A Signs Partnership Agreement to Address Sexual and Reproductive Health and Rights in East Africa
2013
6 August

Conference contemplations: ‘Pharmaceuticals and global health – inequalities and innovation in the 21st century’
10 June

Despite concrete steps forward, the ENVI vote on clinical trials regulation falls short on transparency
2011
15 July

Study provides recommendations on European Medicines Agency's communication on medicines
30 June

TRIPS-Plus IP demands from EU could halt South American trade deal
23 June

EU Mercosur Trade Negotiations in July
23 June

HAI Europe’s participation at the “Ad hoc meeting – Bilateral trade negotiations: State of Play”
22 June

Conflicts of interest at the European Medicines Agency (EMA) and the need for a review of staff regulations
21 June

Submission to the Consultative Expert Working Group (CEWG) on alternative financing
24 May

HAI Europe injects public health perspective into European Research and Innovation Framework
2010
24 November

Invitation: Meeting to discuss Global Health Education (GHE) and the People's Health Movement (PHM) in Europe
22 October

Report: Public information as a medicines marketing tool
8 June

Medicines manufacturers have clear motives for financing the patient voice
30 March

Patient advocacy groups: another tool to boost compliance?